Summary: Researchers successfully sequenced the entire Y chromosome, previously considered the most elusive part of the human genome.
This feat enhances DNA sequencing accuracy for this chromosome, aiding the identification of genetic disorders. Using state-of-the-art technologies, the team pieced together over 62 million letters of genetic code.
This breakthrough, in tandem with the previous reference genome T2T-CHM13, offers the first complete genome for those with a Y chromosome.
Shares of Taiwan Semiconductor Manufacturing Corp, which manufactures all of Nvidia’s advanced AI semiconductors climbed as much as 1.81%
Mezli chef Eric Minnich designed a menu for both diner’s delight and ease of robotic cooking.
A new efficient system of cancer treatment using vitamin k3 (Vk3)-loaded copper zinc ferrite nanoparticles having therapeutic capabilities, could benefit millions of cancer patients worldwide.
With the ever-increasing prevalence of cancer cases worldwide, newer approaches to cancer therapy are increasingly needed to tackle the problem. Since conventional cancer therapies such as chemotherapy, radiation therapy and surgery have significant drawbacks such as resistance to chemotherapeutic drugs, adverse effects and lower efficacy, development of nanotherapies that can target hypoxic (when oxygen is not available in sufficient amounts at the tissue level) tumors, with minimum side-effects is necessary.
At present, magnetic hyperthermia-based cancer therapy (MHCT) therapy has been shown to be therapeutic. However, in most cases, it is not as effective due to the generation of lower levels of reactive oxygen species (ROS) in a hypoxic tumor microenvironment (TME) and low heat transmission.
Peter Diamandis is best known as the founder of the XPrize Foundation, which offers big cash prizes as an incentive for tech solutions to big problems. The entrepreneur and investor is also co-founder of the Singularity University, a Silicon Valley-based nonprofit offering education in futurology. His new book, The Future Is Faster Than You Think, argues that the already rapid pace of technological innovation is about to get a whole lot quicker.
Do you think people are worried about where technology is going to take us? I can palpably feel how fast things are changing and that the rate of change is accelerating, and I have picked up a growing amount of fear coming from people who don’t understand where the world is going. And that is not good when you’re trying to solve problems. This book is about giving people a roadmap for where things are going over the next decade so they have less fear and more anticipation. Because, yes, in the next 10 years, we’re going to reinvent every industry on this planet, but the change is one that is for the benefit of masses, whether it’s in longevity or food or banking.
Google is secretly showing off an AI tool that can produce news stories to major newspapers, including The New York Times, The Washington Post, and The Wall Street Journal.
The tool, dubbed Genesis, can digest public information and generate news content, according to reporting by the New York Times, in yet another sign that AI-generated — or at least AI-facilitated — content is about to flood the internet.
Google is stridently denying that the tool is meant to replace journalists, saying it will instead serve as a “kind of personal assistant for journalists, automating some tasks to free up time for others.”
Researchers from the University of Cambridge have unveiled a surprising discovery that holds the potential to reshape the landscape of electrochemical devices. This new insight opens the door for the creation of cutting-edge materials and paves the way for enhancements in sectors like energy storage, neuromorphic computing, and bioelectronics.
Electrochemical devices rely on the movement of charged particles, both ions, and electrons, to function properly. However, understanding how these charged particles move together has presented a significant challenge, hindering progress in creating new materials for these devices.
In the rapidly evolving field of bioelectronics, soft conductive materials known as conjugated polymers are used for developing medical devices that can be used outside of traditional clinical settings. For example, this type of material can be used to make wearable sensors that monitor patients’ health remotely or implantable devices that actively treat disease.
Dr. Joni L. Rutter, Ph.D., (https://ncats.nih.gov/director/bio) is the Director of the National Center for Advancing Translational Sciences (NCATS — https://ncats.nih.gov/) at the U.S. National Institutes of Health (NIH) where she oversees the planning and execution of the Center’s complex, multifaceted programs that aim to overcome scientific and operational barriers impeding the development and delivery of new treatments and other health solutions. Under her direction, NCATS supports innovative tools and strategies to make each step in the translational process more effective and efficient, thus speeding research across a range of diseases, with a particular focus on rare diseases.
By advancing the science of translation, NCATS helps turn promising research discoveries into real-world applications that improve people’s health. The NCATS Strategic Plan can be found at — https://ncats.nih.gov/strategicplan.
In her previous role as the NCATS deputy director, Dr. Rutter collaborated with colleagues from government, academia, industry and nonprofit patient organizations to establish robust interactions with NCATS programs.
Prior to joining NCATS, Dr. Rutter served as the director of scientific programs within the All of Us Research Program, where she led the scientific programmatic development and implementation efforts to build a national research cohort of at least 1 million U.S. participants to advance precision medicine. During her time at NIH, she also has led the Division of Neuroscience and Behavior at the National Institute on Drug Abuse (NIDA). In this role, she developed and coordinated research on basic and clinical neuroscience, brain and behavioral development, genetics, epigenetics, computational neuroscience, bioinformatics, and drug discovery. Dr. Rutter also coordinated the NIDA Genetics Consortium and biospecimen repository.
Ever wonder why the most advanced robots always seem to have hard bodies? Why not more pliable ones, like humans have?
Researchers working on so-called “soft robotics” attempt to incorporate the feel of living organisms into their creations. But the field hasn’t taken off because the softer components haven’t been easy enough to mass-produce and incorporate into the designs—until now.
University of Virginia researchers have invented a manufacturing process for weaving soft materials such as fabrics, rubbers and gels so that they can be compatible with gadgets, which may lead to a soft robotics revolution.
